CAR T Promises Longer Relief For Myasthenia Gravis

mRNA CAR T therapy Descartes‑08 targets BCMA‑positive plasma cells and delivers year‑long symptom relief in myasthenia gravis after a brief course, signaling a new era of durable treatment.
By Published On: Febbraio 6, 2026Categories: DesignCommenti disabilitati su CAR T Promises Longer Relief For Myasthenia Gravis

Share This Story, Choose Your Platform!

About the author : admin